GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Total Liabilities

G.Barekat Pharm (XTEH:BRKT1) Total Liabilities : IRR24,253,612 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Total Liabilities?

G.Barekat Pharm's Total Liabilities for the quarter that ended in Mar. 2017 was IRR24,253,612 Mil.

G.Barekat Pharm's quarterly Total Liabilities stayed the same from . 20 (IRR0.00 Mil) to Mar. 2016 (IRR0.00 Mil) but then increased from Mar. 2016 (IRR0.00 Mil) to Mar. 2017 (IRR24,253,612.00 Mil).

G.Barekat Pharm's annual Total Liabilities stayed the same from . 20 (IRR0.00 Mil) to Mar. 2016 (IRR0.00 Mil) but then increased from Mar. 2016 (IRR0.00 Mil) to Mar. 2017 (IRR24,253,612.00 Mil).


G.Barekat Pharm Total Liabilities Historical Data

The historical data trend for G.Barekat Pharm's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Total Liabilities Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Total Liabilities
- 24,253,612.00

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Total Liabilities - 24,253,612.00

G.Barekat Pharm Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

G.Barekat Pharm's Total Liabilities for the fiscal year that ended in Mar. 2017 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=23783434+(255897+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+214281)
=24,253,612

Total Liabilities=Total Assets (A: Mar. 2017 )-Total Equity (A: Mar. 2017 )
=34818314-10564702
=24,253,612

G.Barekat Pharm's Total Liabilities for the quarter that ended in Mar. 2017 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=23783434+(255897+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+214281)
=24,253,612

Total Liabilities=Total Assets (Q: Mar. 2017 )-Total Equity (Q: Mar. 2017 )
=34818314-10564702
=24,253,612

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G.Barekat Pharm Total Liabilities Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines